Target intelligence / Profile preview

Spike-E-M mosaic protein of SARS-CoV-2 (SEM mosaic protein (unofficial; not an established abbreviation in the literature))

Target
SEM mosaic protein (unofficial; not an established abbreviation in the literature)
Molecular classification
Other (Recombinant protein, antigen)
01

Overview

The Spike-E-M mosaic protein of SARS-CoV-2 is a recombinant antigen produced in *E. coli*, incorporating selected immunodominant epitopes from the virus's Spike, Envelope, and Membrane proteins. It is engineered for use in lab assays (such as ELISA) to detect antibodies against SARS-CoV-2[7]. It is not a naturally occurring, functional molecule in the virus or human host, nor is it considered a therapeutic or pharmacological target.

Other names
Spike-E-M mosaic proteinSARS-CoV-2 Spike-E-M Mosaic recombinant antigen
02

Biological functions

Other (Used as diagnostic or assay antigen; not a natural viral protein)

Beyond the preview

Go deeper on Spike-E-M mosaic protein of SARS-CoV-2 (SEM mosaic protein (unofficial; not an established abbreviation in the literature)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spike-E-M mosaic protein of SARS-CoV-2 (SEM mosaic protein (unofficial; not an established abbreviation in the literature)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call